Govt Cuts Price of 3 Anti-Cancer Drugs - Trastuzumab, Osimertinib, Durvalumab
India's government has asked manufacturers to reduce prices of three anti-cancer drugs - Trastuzumab, Osimertinib and Durvalumab - to reflect tax cuts. This follows a customs duty exemption and...
Oct 29, 2024 16:25